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ORIGINAL ARTICLE
In Taiwan, Kawasaki disease (KD) was first diag-
nosed in 1976, and has continued to occur with
several outbreaks, reaching a peak incidence of
54.9 per 100,000 people aged < 5 years in 1998.1
KD is a systemic vasculitis in early childhood 
of unknown etiology, which is characterized by
prolonged high fever, polymorphous skin rash,
conjunctivitis, inflammation of mucous mem-
branes, edema of the peripheral extremities, and
cervical lymphadenopathy. KD leads to coronary
artery lesions, and even to life-threatening myo-
cardial infarction. Cytokines such as tumor necro-
sis factor-α, interferon-γ, interleukin (IL)-1 and
IL-6 act on hepatocytes to induce synthesis of
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Background/Purpose: The aim of this study was to understand the association between Kawasaki disease
(KD) in children and serum high-sensitivity C-reactive protein (hs-CRP), which is a sensitive indicator of
inflammation, lipid profiles and coronary artery lesions.
Methods: Between July 2005 and December 2007, 119 children with KD at least 1 year after diagnosis were
recruited. The children were classified into one of two groups: Group I comprised 55 children with KD
and coronary aneurysms; Group 2 comprised 64 children with KD and normal coronary arteries. The rela-
tionship between hs-CRP concentration and high-density lipoprotein cholesterol (HDL-C) and the size of
arterial lesions was investigated in Group I 1 year after onset of KD.
Results: Serum hs-CRP levels in Group I (mean, 0.251mg/dL) were significantly greater than those in
Group II (mean, 0.162mg/dL; p = 0.011). However, plasma HDL-C levels in Group I (mean 42.51 mg/dL)
were significantly lower than those in Group II (mean, 44.34 mg/dL; p = 0.037). In Group I, there was a
positive association between hs-CRP and the size of coronary artery lesions (r = 0.672, p = 0.035), but no
association between lipid profiles, including HDL-C, and coronary artery lesions (all p > 0.05).
Conclusion: Our results support the possibility of ongoing low-grade inflammation late after the acute
phase of KD in children with coronary aneurysms. Serum hs-CRP and HDL-C levels are associated with
coronary artery lesions in children with KD. [J Formos Med Assoc 2009;108(9):719–724]
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acute phase proteins, including C-reactive pro-
tein (CRP), and appear to play important roles in
the pathophysiology of the disease.2 Importantly,
the presence of systemic markers of inflamma-
tion associated with an unfavorable short-term
prognosis in patients with acute coronary syn-
drome, and elevated high-sensitivity CRP (hs-CRP)
are related to long-term prognosis in patients
with documented coronary disease.3–5 These fac-
tors show a positive correlation, which suggests
that chronic low-grade arterial inflammation is
possible even years after resolution of the acute
phase of KD.
Lipid profiles have been measured as predic-
tors of atherosclerosis in several studies.6 Lipid
profiles play an important role in atherosclerosis
in children with KD and coronary artery lesions
(CALs) and aneurysms. Given the preliminary
evidence of late artery dysfunction in KD, and a
possible link between chronic inflammation and
the risk of developing cardiovascular disease, we
hypothesize that low-grade inflammation persists
for years in children with KD and CALs after res-
olution of the acute phase. Thus, we evaluated the
serum hs-CRP concentration and lipid profile,
including high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol
(LDL-C), total cholesterol, and triglycerides, of
children with KD.
Patients and Methods
Between July 2005 and December 2007, 198
children aged 3 months to 18 years with a diag-
nosis of KD were recruited in the Department of
Pediatrics at Kaohsiung Veterans General Hospital.
The participating children had been diagnosed
with KD between January 2001 and December
2004. The diagnosis of KD was based on the crite-
ria of prolonged high fever, polymorphous skin
rash, conjunctivitis, inflammation of mucous
membranes, edema of the peripheral extremities,
and cervical lymphadenopathy, which were re-
vised in 1984 by the KD Research Committee in
Japan. One hundred and forty-two children were
enrolled in this study. Written informed consent
was obtained from the parents of each patient.
Eighteen children with signs of infection, such as
fever, cough, rhinorrhea, diarrhea and vomiting,
during this time were excluded. Five children were
lost during follow-up. Thus, only 119 children
participated in this study. The participants were
categorized into two groups, as evaluated by
echocardiography: Group I comprised 55 chil-
dren with KD and persistent CALs, including
aneurysms, stenosis and occlusion; and Group II
comprised 64 children with KD without coro-
nary aneurysms or ectasia at disease onset. All
the children underwent detailed clinical exami-
nation for the assessment of their general and
cardiac conditions. Patient records were collected
to evaluate cardiac status. Children who had KD
within 6 months of the study were excluded to
minimize a potentially confounding influence re-
lating to subacute inflammation. Those with in-
fectious diseases within 1 month before the study
were also excluded. The following data were re-
trieved from the patients’ medical records: age,
sex, body mass index, systolic and diastolic blood
pressure, use of intravenous immunoglobulin
(IVIG) during the acute phase, coronary artery
complications, and duration from onset of dis-
ease to the time of the study. Of the 119 children
with KD, 104 were treated with IVIG once (2 g/
kg/day over 10 hours), 10 were treated with IVIG
twice, and five were treated with IVIG three times
because of persistent fever. Thirty-eight children
with KD were treated orally for 6 weeks with aspirin
(3–5 mg/kg/day) and dipyridamole (4–6 mg/kg/
day) divided into two doses, 28 were treated for
7 weeks, 25 for 8 weeks, and 25 for 9 weeks.
Venous blood samples were collected at the
time of the clinical examination and stored at 
−80°C before analysis. The average time interval
from KD onset to venous blood sampling was
2.46 years. Serum CRP was measured with a highly
sensitive particle-enhanced immunoturbidimet-
ric assay that consisted of an anti-CRP mono-
clonal antibody coupled to latex microparticles
(IMMULITE®; Siemens, Deerfield, IL, USA). The
following variables were considered as potential
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risk factors for CALs: age at study, age at KD onset,
sex, duration from diagnosis to time of study, body
mass index, systolic and diastolic blood pressure,
and lipid profile. The laboratory staff were blinded
to the clinical data.
Two-dimensional echocardiography was per-
formed in all children at the time of diagnosis,
repeated in the second week of illness and then
at 1, 3, 6 and 12 months. The CALs during the
acute phase were defined as aneurismal as follows:
(1) internal lumen diameter ≥ 3 mm in children
< 5 years of age; (2) internal lumen diameter
≥ 4 mm in children ≥ 5 years; and (3) internal 
diameter of a segment at least 1.5 times as large
as that of an adjacent segment.
Statistical analyses were performed using un-
paired Student’s t test on continuous variables
and χ2 test on discrete variables from children
with KD with or without CALs. For comparison
of two groups of nonparametric variables, the
Mann–Whitney U test was used. Within Group I,
Pearson’s correlation analysis was used to assess
a possible relationship between hs-CRP, lipid pro-
file, and changes in CALs. To show the correla-
tion of detailed changes between CRP and CALs,
we used logarithmic hs-CRP.
Results
Patient sample
Group I comprised 55 children with KD, 40 of
whom had persistent small coronary aneurysms.
None had symptoms of myocardial ischemia
and none required coronary artery interventions.
Group II comprised 64 children with KD but
without documented CALs. Of the total of 119
children with KD, 104 received IVIG once, 10 
received IVIG twice, and five received IVIG three
times during the acute phase of illness. All patients
continued to receive long-term, oral, low-dose
aspirin. The Table summarizes the demographic,
hemodynamic, and lipid profiles of the two
groups. The groups did not differ significantly with
regard to age at presentation, age at the time of
study, sex distribution, body mass index, systemic
and diastolic blood pressure, LDL-C, triglycerides,
and total cholesterol concentration. However,
hs-CRP and HDL-C levels did differ significantly 
between the two groups.
Serum hs-CRP and HDL-C levels
Twenty-two of the children had an hs-CRP con-
centration lower than the detectable limit, which
was assigned a value of 0.01mg/dL. The mean 
hs-CRP concentration in Group I (0.251mg/dL)
was significantly greater than that in Group II
(0.162 mg/dL; p = 0.011, Mann–Whitney U test)
(Figure 1). Mean HDL-C level in Group I
(42.51 mg/dL) was significantly lower than that
in Group II (44.34 mg/dL; p = 0.037). There was
no significant correlation between serum hs-CRP
and HDL-C levels (p>0.05) according to Pearson’s
correlation analysis.
Correlation between CAL size and hs-CRP
and lipid profile in Group I
There was a significant positive correlation be-
tween logarithmic hs-CRP level and CAL size
(r = 0.672, p = 0.035) (Figure 2), but no associa-
tion between lipid profile, including HDL-C, and
CAL size (all p > 0.05).
Discussion
Coronary artery aneurysm or dilatation occurs in
approximately 5–16% of patients with KD, de-
spite the introduction of high-dose IVIG treat-
ment.2 Coronary aneurysm is responsible for
most of the mortality of KD, therefore, it is es-
sential to determine the risk factors for the devel-
opment of coronary aneurysm to establish a better
treatment strategy. Recent reviews regarding the
role of chronic inflammation in the evolution of
the atherosclerotic process, namely, formation 
of the atheroma plaque, have been summarized
briefly.3,4 These events point to the possibility that
inflammatory makers constitute new markers of
cardiovascular risk. Moreover, histological exam-
ination has shown extensive fibrointimal thick-
ening and infiltration of lymphocytes and plasma
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cells into the coronary arterial walls.7,8 These
findings suggest that chronic, low-grade arterial
inflammation is possible even years after resolu-
tion of the acute phase of KD. Inflammatory
processes play a pivotal role in atherogenesis,
which may account for initiation and progression
of atherosclerosis.
Increased concentrations of hs-CRP have been
found to predict myocardial ischemia, and sud-
den death among adult patients with multiple
risk factors for coronary artery disease.9,10 CRP
has been shown to possess proatherogenic prop-
erties, and to be part of the innate immunity that
activates the classical complement pathway after
aggregation or binding to ligands.9–11 CRP acti-
vates endothelial cells to express adhesion mole-
cules, cytokines, and chemokines.12 CRP activates
macrophages to express cytokines, enhances the
uptake of LDL-C, and decreases HDL-C.6 Increased
hs-CRP concentrations in the presence of associ-
ated coronary aneurysms are probably a reflection
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Table. Demographics, hemodynamics and lipid profiles of the two groups
Group I (n = 55) Group II (n = 64) p
Age at study (yr) 4.23 ± 3.81 4.41 ± 4.25 0.519
Age at diagnosis of Kawasaki disease (yr) 1.85 (0.51–5.74) 2.02 (0.63–6.24) 0.151
Interval from diagnosis to study time (yr) 2.46 (0.71–4.62) 2.52 (1.12–4.92) 0.249
Sex (male:female) 32:23 34:30 0.769
Body mass index (kg/m2) 19.27 ± 0.46 18.29 ± 1.32 0.874
Systolic blood pressure (mmHg) 111.56 ± 9.43 110.08 ± 8.29 0.165
Diastolic blood pressure (mmHg) 55.33 ± 5.18 55.65 ± 7.35 0.355
Triglyceride (mg/dL) 109 ± 92.13 113 ± 54.15 0.664
Total cholesterol (mg/dL) 151.72 ± 10.91 150.44 ± 16.86 0.289
HDL cholesterol (mg/dL) 42.51 ± 10.23 44.34 ± 10.91 0.037*
LDL cholesterol (mg/dL) 91.04 ± 11.9 91.3 ± 14.44 0.511
hs-CRP (mg/dL) 0.251 ± 0.169 0.162 ± 0.172 0.011*
*Significant difference. HDL = high-density lipoprotein; LDL = low-density lipoprotein; hs-CRP = high-sensitivity C-reactive protein.
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Figure 1. Distribution of (A) serum high-sensitivity C-reactive protein (hs-CRP) and (B) high-density lipoprotein choles-
terol (HDL-C) in the two groups.
Figure 2. Correlation between logarithmically transformed
levels of high-sensitivity C-reactive protein (CRP) and the
size of coronary artery lesions (CALs) in Kawasaki disease.
of continuing low-grade vasculitis, and might be
associated with long-term endothelial dysfunc-
tion observed in children with KD.13,14 Therefore,
the present data are consistent with the hypothe-
sis that the inflammatory process is involved in
the progression of CALs in children with KD,
and coronary events in adolescents and young
adults. Our findings of increased baseline hs-CRP
concentrations after the convalescent phase of
KD in children with CALs may therefore have
important implications.
Whether it is essential to measure plasma lev-
els of atherosclerotic markers in clinical practice
remains to be elucidated. Plasma lipid profiles,
such as triglycerides, total cholesterol, LDL-C and
HDL-C levels, can be measured as predictors of
atherosclerosis, and are associated with people
who have coronary arterial diseases.6,15 A recent
study has shown that the potential effect of in-
flammation on coronary risk in patients with
coronary dysfunction is correlated with HDL-C
levels, which suggests that HDL-C may be useful
for the prevention of future cardiovascular risk in
KD patients.16 Evidence also suggests that HDL-C
may be directly anti-inflammatory. In our study,
HDL-C levels were significantly decreased in chil-
dren with KD and CALs compared with those
without CALs. However, there was no association
between other lipid profiles and KD with CALs.
Since hs-CRP level was significantly greater
and HDL-C level was significantly lower in KD
children with CALs compared to without CALs,
we investigated the relationship between hs-CRP
and HDL-C levels and the extent of atherosclerotic
changes in children with KD and CALs. There
was a positive association between hs-CRP and
the size of CALs (r = 0.672, p = 0.035), but no
such association between HDL-C levels and size
of CALs (all p > 0.05). The association between
serum hs-CRP and KD in children with arterial
stiffness has been described recently by Cheung
and colleagues.3 Our findings corroborate theirs,
and further show that children with CALs have 
a positive association between hs-CRP and the
size of CALs. However, there was no association
between HDL-C levels and the size of CALs. The
reason for the relationship with hs-CRP but not
with HDL-C might be the high sensitivity of CRP,
which is influenced by cytokines to cause vas-
culitis and alter the structure of the arterial wall.
This suggests that levels of hs-CRP are not only
elevated in children with KD and CALs, but can
also predict the size of the CAL.
There was a controversy in the present study.
It may be argued that Group I comprised children
with KD and persistence or regression of CALs,
and might not have been homogeneous. However,
the similar morphological and functional coro-
nary abnormalities to those reported previously
suggest that these children shared similar features
of arterial dysfunction.3,17 Therefore, we combined
these two subsets into a single group for analysis.
A greater number of patients are required to con-
firm that hs-CRP concentration is similar between
the two subsets.
In children with KD and CALs, serum hs-CRP
is elevated significantly and HDL-C level is de-
creased after the convalescent phase, compared
with those without CALs. These serum levels may
serve as good predictors for the later phase of KD
in children regarding the development of CALs.
Our results support the possibility of ongoing low-
grade inflammation after the convalescent phase
of KD in children with coronary aneurysms, which
may have a role in increasing coronary artery
dysfunction. Except for subjective performance of
cardiac echography, these laboratory data may be
helpful because serum hs-CRP and plasma HDL-C
levels are analyzed routinely in hospitals.
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